Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.78B
| $1.64M | ﹤0.01% |
25,300
+2,400
| +10% | +$148K |
|
|
AFCG
2202
AFC Gamma
AFCG
$63.4M
| $1.64M | ﹤0.01% |
152,236
+12,564
| +9% | +$141K |
|
2203
Crown Crafts
CRWS
$32.1M
| $1.64M | ﹤0.01% |
306,942
-14,176
| -4% | -$81.6K |
|
2204
Ligand Pharmaceuticals
LGND
$6.06B
| $1.64M | ﹤0.01% |
24,500
-2,270
| -8% | -$148K |
|
2205
Sypris Solutions
SYPR
$47.7M
| $1.64M | ﹤0.01% |
798,021
-35,008
| -4% | -$72.9K |
|
2206
Kura Sushi USA
KRUS
$598M
| $1.63M | ﹤0.01% |
34,157
-21,043
| -38% | -$1.4M |
|
2207
PCB Bancorp
PCB
$397M
| $1.63M | ﹤0.01% |
91,998
-2,303
| -2% | -$42.9K |
|
|
HA
2208
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.63M | ﹤0.01% |
158,600
+65,300
| +70% | +$872K |
|
2209
Riverview Bancorp
RVSB
$109M
| $1.63M | ﹤0.01% |
211,607
-15,200
| -7% | -$108K |
|
|
AHT
2210
Ashford Hospitality Trust
AHT
$21M
| $1.62M | ﹤0.01% |
36,297
+560
| +2% | +$36.1K |
|
2211
Citizens & Northern Corp
CZNC
$453M
| $1.62M | ﹤0.01% |
70,741
-4,800
| -6% | -$115K |
|
2212
Alamo Group
ALG
$2.04B
| $1.61M | ﹤0.01% |
11,400
+2,100
| +23% | +$304K |
|
2213
Glaukos
GKOS
$10.1B
| $1.61M | ﹤0.01% |
36,765
-66,435
| -64% | -$3.28M |
|
2214
Innoviz Technologies
INVZ
$116M
| $1.61M | ﹤0.01% |
408,600
+38,400
| +10% | +$183K |
|
2215
Annexon
ANNX
$880M
| $1.6M | ﹤0.01% |
310,100
-20,100
| -6% | -$110K |
|
|
NSTG
2216
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.6M | ﹤0.01% |
+200,500
| New | +$1.74M |
|
2217
Schwab US Dividend Equity ETF
SCHD
$105B
| $1.59M | ﹤0.01% |
63,300
-68,100
| -52% | -$1.68M |
|
2218
MasterCraft Boat Holdings
MCFT
$610M
| $1.59M | ﹤0.01% |
61,400
+8,700
| +17% | +$205K |
|
2219
Princeton Bancorp
BPRN
$287M
| $1.58M | ﹤0.01% |
49,965
+4,142
| +9% | +$129K |
|
|
KE
2220
Kimball Electronics
KE
$644M
| $1.58M | ﹤0.01% |
70,175
-10,100
| -13% | -$216K |
|
2221
BBVA Argentina
BBAR
$3.65B
| $1.58M | ﹤0.01% |
405,786
+169,620
| +72% | +$523K |
|
2222
CAE Inc. Common Shares
CAE
$8.62B
| $1.58M | ﹤0.01% |
81,800
-576,946
| -88% | -$11.1M |
|
2223
Samsara
IOT
$22.6B
| $1.58M | ﹤0.01% |
+127,300
| New | +$1.45M |
|
2224
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $1.58M | ﹤0.01% |
89,800
+14,900
| +20% | +$254K |
|
|
ALEX
2225
DELISTED
Alexander & Baldwin
ALEX
| $1.58M | ﹤0.01% |
84,300
-39,400
| -32% | -$746K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.